Myasthenia gravis and multiple sclerosis: An uncommon presentation

Arquivos de Neuro-Psiquiatria

Volumn 66, Issue 2 A, 2008, Pages 251-253

  Lorenzoni, Paulo J ^a   Scola, Rosana Herminia ^a   Kamoi Kay, Cláudia S ^a   Werneck, Lineu C ^a  

^a FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; METHYLPREDNISOLONE; PREDNISONE; PYRIDOSTIGMINE;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE ASSOCIATION; FEMALE; HUMAN; MULTIPLE SCLEROSIS; MUSCLE WEAKNESS; MYASTHENIA GRAVIS; PTOSIS;

EID: 45849121297     PISSN: 0004282X     EISSN: 16784227     Source Type: Journal    
DOI: 10.1590/S0004-282X2008000200023     Document Type: Article

References (15)

1. Cunha FMB, Scola RH, Werneck LC. Myasthenia gravis: clinical evaluation of 153 patients. Arq Neuropsiquiatr 1999;57:457-464.
2. Arruda WO, Scola RH, Teive HAG, Werneck LC. Multiple sclerosis: report on 200 cases from Curitiba, Southern Brazil and comparison with others Brazilian series. Arq Neuropsiquiatr 2001;59:165-170.
3. Somer H, Muller K, Kinnunen E. Myasthenia gravis associated with multiple sclerosis, epidemiological survey and immunological findings. J Neurol Sci 1989;89:37-48.
4. Isbister CM, Mackenzie PJ, Anderson D, Wade NK, Oger J. Co-occurrence of multiple sclerosis and myasthenia gravis in British Columbia. Mult Scler 2003;9:550-553.
5. Sanchez JL, Uribe CS, Franco A, Jimenez ME, Arcos-Burgos M, Palacio LG. Prevalence of myasthenia gravis in Antioquia, Colômbia. Rev Neurol 2002;34:1010-1012.
6. Assis JL. Miastenia gravis. São Paulo: Savier, 1990: 10.
7. Callegaro D, Goldbaum M, Morais L, et al. The prevalence of multiple sclerosis in the city of São Paulo, Brazil, 1997. Acta Neurol Scand 2001;104:208-213.
8. Carvalho MF, Abrahão TCM, Assaf M. Systemic lupus erythematosus and myasthenia gravis: case report. Arq Neuropsiquiatr 1998;56:137-140.
9. Keesey JC. Does myasthenia gravis affect the brain? J Neurol Sci 1999;170:77-89.
10. Gotkine M, Fellig Y, Abramsky O. Occurrence of CNS demyelinating disease in patients with myasthenia gravis. Neurology 2006;67:881-883.
11. Collard RC, Koehler RPM, Mattson DH. Frequency and significance of antinuclear antibodies in multiple sclerosis. Neurology 1997;49:857-861.
12. Sthoeger Z, Neiman A, Elbirt D, et al. High prevalence of systemic lupus erythematosus in 78 myasthenia gravis patients: a clinical and serologic study. Am J Med Sci 2006;331:4-9.
13. Barned S, Goodman AD, Mattson DH. Frequency of anti-nuclear antibodies in multiple sclerosis. Neurology 1995;45:384-385.
14. Dionisiotis J, Zoukos Y, Thomaides T. Development of myasthenia gravis in two patients with multiple sclerosis following interferon b treatment. J Neurol Neurosurg Psychiatry 2004;75:1076-1079.
15. Frese A, Bethke F, Lüdemann P, Stögbauer F. Development of myasthenia gravis in a patient with multiple sclerosis during treatment with glatiramer acetate. J Neurol 2000;247:713.